Literature DB >> 3509283

Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine.

B S Chakraborty1, M S Sardessai, T J Jaworski, K K Midha, E M Hawes.   

Abstract

For the separate development of radioimmunoassay procedures for thioridazine and its two major active metabolites, mesoridazine and sulforidazine, three haptens, respectively, 2-methylthio-, 2-methylsulfinyl-, and 2-methylsulfonyl-substituted 10-[2-[1-(2-carboxyethyl)-2-piperidinyl]ethyl]-10H-phenothiazine, were synthesized and characterized. Thioridazine hapten was coupled to bovine serum albumin, whereas the haptens for mesoridazine and sulforidazine were coupled to porcine thyroglobulin. The number of hapten residues per mole of carrier protein was determined in each case by an ultraviolet spectrophotometric method. Polyclonal antibodies to each hapten-protein conjugate were obtained in rabbits, and titers of the antisera were checked by evaluating their binding characteristics to the appropriate tritiated analyte. A hapten for the ring sulfoxide metabolite of thioridazine was also synthesized.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509283     DOI: 10.1023/a:1016451926984

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Steroid-protein conjugates. II. Preparation and characterization of conjugates of bovine serum albumin with progesterone, deoxycorticosterone, and estrone.

Authors:  B F ERLANGER; F BOREK; S M BEISER; S LIEBERMAN
Journal:  J Biol Chem       Date:  1959-05       Impact factor: 5.157

2.  Steroid-protein conjugates. I. Preparation and characterization of conjugates of bovine serum albumin with testosterone and with cortisone.

Authors:  B F ERLANGER; F BOREK; S M BEISER; S LIEBERMAN
Journal:  J Biol Chem       Date:  1957-10       Impact factor: 5.157

3.  Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.

Authors:  E Mårtensson; G Nyberg; R Axelsson; K Serck-Hansen
Journal:  Curr Ther Res Clin Exp       Date:  1975-11

4.  Radioimmunoassay for the sulfoxide metabolite of trifluoperazine and its application to a kinetic study in humans.

Authors:  M Aravagiri; E M Hawes; K K Midha
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

5.  Radioimmunoassay for psychotropic drugs I: synthesis and properties of haptens for chlorpromazine.

Authors:  J W Hubbard; K K Midha; I J McGilveray; J K Cooper
Journal:  J Pharm Sci       Date:  1978-11       Impact factor: 3.534

6.  A pilot of plasma thioridazine and metabolites in chronically treated patients.

Authors:  A S Papadopoulos; T G Chand; J L Crammer; S Lader
Journal:  Br J Psychiatry       Date:  1980-06       Impact factor: 9.319

7.  Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.

Authors:  A Shvartsburd; V Nwokeafor; R C Smith
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  A comparison of two radioimmunoassays for 7-hydroxychlorpromazine: rabbit polyclonal antibodies vs. mouse monoclonal antibodies.

Authors:  P K Yeung; G McKay; I A Ramshaw; J W Hubbard; K K Midha
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

9.  Partitioning of thioridazine and mesoridazine in human blood fractions.

Authors:  E C Dinovo; H Pollak; L A Gottschalk
Journal:  Methods Find Exp Clin Pharmacol       Date:  1984-03

10.  Radioimmunoassay for psychotropic drugs II: synthesis and properties of haptens for tricyclic antidepressants.

Authors:  J W Hubbard; K K Midha; J K Cooper; C Charette
Journal:  J Pharm Sci       Date:  1978-11       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.